INT330979

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.02
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.84
Pain Relevance 0.06

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

NARFL (Homo sapiens)
Pain Link Frequency Relevance Heat
eye pain 1 61.12 Quite High
Inflammation 34 50.00 Quite Low
Pain 20 50.00 Quite Low
cva 1 12.00 Low Low
corticosteroid 5 5.00 Very Low Very Low Very Low
cINOD 4 5.00 Very Low Very Low Very Low
withdrawal 2 5.00 Very Low Very Low Very Low
fibrosis 1 5.00 Very Low Very Low Very Low
Inflammatory mediators 1 5.00 Very Low Very Low Very Low
visual analogue scale 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Ocular Hypertension 17 100.00 Very High Very High Very High
Conjunctivitis 1 66.32 Quite High
Corneal Edema 3 65.56 Quite High
Increased Venous Pressure Under Development 2 63.84 Quite High
Eye Pain 1 61.12 Quite High
Pain 20 50.00 Quite Low
Ocular & Orbital Inflammation 17 50.00 Quite Low
Cataract 4 50.00 Quite Low
INFLAMMATION 19 42.72 Quite Low
Toxicity 1 19.28 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Among the 9 subjects (11.1%) in the difluprednate group reported to have an increased IOP, 5 (6.2%) were considered related to the study drug, and 3 (3.7%) of these were considered clinically significant.
Protein_catabolism (have) of IOP associated with ocular hypertension
1) Confidence 0.02 Published 2010 Journal Clinical Ophthalmology (Auckland, N.Z.) Section Body Doc Link PMC2938279 Disease Relevance 0.84 Pain Relevance 0.06

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox